Position in HLN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$522
-$398 QoQ
Shares Held
56
-39.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#620
of 640 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HIGHLINE WEALTH PARTNERS LLC holds $231,239 across 10 Drug Manufacturers - Specialty & Generic names. HLN ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
351 | $190,182 | |
| 2 | VTRS |
Viatris Inc
|
750 | $11,910 | |
| 3 | ZTS |
Zoetis Inc.
|
118 | $8,479 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
274 | $6,743 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
296 | $4,744 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
27 | $4,550 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
46 | $1,558 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
98 | $1,420 |
All Filings in HLN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $522 | 56 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $920 | 92 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $930 | 92 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,560 | 174 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,399 | 135 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,389 | 135 | Shares | Sole | 2025-04-17 | |
| 2023-12-31 | $0 | 0 | Shares | Sole | 2024-10-29 | |
| 2023-09-30 | $216 | 26 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||